1. Intracellular degradation of sulforhodamine-GM1: Use for a fluorescence-based characterization of GM2 gangliosidosis variants in fibroblasts and white blood cells;Agmon;Clin. Chim. Acta,1996
2. Clinical and genetic variations in the syndrome of GM2 gangliosidosis due to hexosaminidase A deficiency;Argov;Ann. Neurol.,1984
3. Tay-Sachs disease in a Moroccan Jewish family. A possible new mutation;Bach;Israel J. Med. Sci.,1976
4. Ganglioside GM2 N-acetyl-β-D-galactosaminidase activity in cultured fibroblasts of late infantile and adult GM2 gangliosidosis and of healthy probands with low hexosaminidase level;Conzelmann;Am. J. Hum. Genet.,1983
5. Faulty association of the α- and β-subunits in some forms of β-hexosaminidase deficiency;d'Azzo;J. Biol. Chem.,1984